Clinical Trial

A Family-centred Approach Enhancing Cardiovascular Health in Ugandan Adolescents and Their Families

Study acronym: FaCe-D
Recruiting
View on ClinicalTrials.gov →
Summary
The FaCe-D Study, with funding from the Canadian Institute for Health Research (CIHR) through Global Alliance for Chronic Diseases (GACD) aims to adapt and implement an evidence-based family centred approach (FCA) to prevent cardiovascular diseases (CVD) among adolescents and their families. This 5-year implementation science study will be conducted in 16 villages in Jinja district and another 16 in Kampala beginning April 2024 to evaluate the effectiveness of FCA in reducing the risk of CVD in Uganda and to assess feasibility, adoption, while measuring the costs of implementation. The study will be implemented by a group of researchers from MRC/UVRI \& LSHTM, University of British Columbia (Canada), TASO (Uganda) and University of California San Francisco (UCSF) - USA with guidance from the Ministry of Health - Uganda.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-02.
Trial Details
NCT Number NCT07265453
Lead Sponsor MRC/UVRI and LSHTM Uganda Research Unit
Collaborators: University of California, The AIDS Support Organization, University of British Columbia
Conditions Adolescent Behavior, Lifestyle Modification, Cardiovascular Disease Other
Enrollment 1,280 participants
Start Date 2025-07-05
Primary Completion 2027-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-12